Hims & Hers Health (HIMS) Price to Sales (2020 - 2026)

Hims & Hers Health has disclosed Price to Sales across 7 years of filings, most recently posting 10.74 for Q2 2026.

• In Q2 2026, Price to Sales fell 48.01% year-over-year to 10.74; the TTM figure through Jun 2026 stood at 3.14 (down 43.87% YoY), while the FY2025 annual figure was 3.14, down 13.09% from the prior year.
• Price to Sales came in at 10.74 for Q2 2026 at Hims & Hers Health, up from 7.88 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 21.54 in Q3 2025 to a low of 5.88 in Q3 2023.
• Average Price to Sales over 5 years is 11.11, with a median of 10.78 recorded in 2022.
• Year-over-year, Price to Sales sank 77.62% in 2022 and jumped 115.61% in 2025.
• Over 5 years, Price to Sales stood at 7.99 in 2022, then decreased by 3.58% to 7.7 in 2023, then jumped by 44.06% to 11.1 in 2024, then advanced by 7.61% to 11.94 in 2025, then retreated by 10.09% to 10.74 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 10.74 in Q2 2026, 7.88 in Q1 2026, and 11.94 in Q4 2025.